{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:07:16Z","timestamp":1792789636139,"version":"4.5.0"},"reference-count":54,"publisher":"American Society for Clinical Investigation","issue":"12","license":[{"start":{"date-parts":[[2023,6,22]],"date-time":"2023-06-22T00:00:00Z","timestamp":1687392000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,6,22]]},"abstract":"<jats:p>\n                    \u02c6CCL24 is a pro-fibrotic, pro-inflammatory chemokine expressed in several chronic fibrotic diseases. In the liver, CCL24 plays a role in fibrosis and inflammation, and blocking CCL24 led to reduced liver injury in experimental models. We studied the role of CCL24 in primary sclerosing cholangitis (PSC) and evaluated the potential therapeutic effect of blocking CCL24 in this disease. Multidrug resistance gene 2\u2013knockout (Mdr2\n                    <jats:sup>\u2013\/\u2013<\/jats:sup>\n                    ) mice demonstrated CCL24 expression in liver macrophages and were used as a relevant experimental PSC model. CCL24-neutralizing monoclonal antibody, CM-101, significantly improved inflammation, fibrosis, and cholestasis-related markers in the biliary area. Moreover, using spatial transcriptomics, we observed reduced proliferation and senescence of cholangiocytes following CCL24 neutralization. Next, we demonstrated that CCL24 expression was elevated under pro-fibrotic conditions in primary human cholangiocytes and macrophages, and it induced proliferation of primary human hepatic stellate cells and cholangiocytes, which was attenuated following CCL24 inhibition. Correspondingly, CCL24 was found to be highly expressed in liver biopsies of patients with PSC. CCL24 serum levels correlated with Enhanced Liver Fibrosis score, most notably in patients with high alkaline phosphatase levels. These results suggest that blocking CCL24 may have a therapeutic effect in patients with PSC by reducing liver inflammation, fibrosis, and cholestasis.\n                  <\/jats:p>","DOI":"10.1172\/jci.insight.162270","type":"journal-article","created":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T14:05:15Z","timestamp":1687356315000},"source":"Crossref","is-referenced-by-count":44,"title":["CCL24 regulates biliary inflammation and fibrosis in primary sclerosing cholangitis"],"prefix":"10.1172","volume":"8","author":[{"given":"Raanan","family":"Greenman","sequence":"first","affiliation":[{"name":"Chemomab Therapeutics Ltd., Tel Aviv, Israel."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Segal-Salto","sequence":"additional","affiliation":[{"name":"Chemomab Therapeutics Ltd., Tel Aviv, Israel."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neta","family":"Barashi","sequence":"additional","affiliation":[{"name":"Chemomab Therapeutics Ltd., Tel Aviv, Israel."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ophir","family":"Hay","sequence":"additional","affiliation":[{"name":"Gene Therapy Institute, Hadassah Hebrew University Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avi","family":"Katav","sequence":"additional","affiliation":[{"name":"Chemomab Therapeutics Ltd., Tel Aviv, Israel."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omer","family":"Levi","sequence":"additional","affiliation":[{"name":"Chemomab Therapeutics Ltd., Tel Aviv, Israel."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilan","family":"Vaknin","sequence":"additional","affiliation":[{"name":"Chemomab Therapeutics Ltd., Tel Aviv, Israel."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Revital","family":"Aricha","sequence":"additional","affiliation":[{"name":"Chemomab Therapeutics Ltd., Tel Aviv, Israel."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarit","family":"Aharoni","sequence":"additional","affiliation":[{"name":"Chemomab Therapeutics Ltd., Tel Aviv, Israel."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Snir","sequence":"additional","affiliation":[{"name":"Chemomab Therapeutics Ltd., Tel Aviv, Israel."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inbal","family":"Mishalian","sequence":"additional","affiliation":[{"name":"Gene Therapy Institute, Hadassah Hebrew University Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devorah","family":"Olam","sequence":"additional","affiliation":[{"name":"Gene Therapy Institute, Hadassah Hebrew University Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johnny","family":"Amer","sequence":"additional","affiliation":[{"name":"Institute of Gastroenterology and Liver Diseases, Department of Medicine, Hadassah Hebrew University Hospital, Jerusalem, Israel."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Salhab","sequence":"additional","affiliation":[{"name":"Institute of Gastroenterology and Liver Diseases, Department of Medicine, Hadassah Hebrew University Hospital, Jerusalem, Israel."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rifaat","family":"Safadi","sequence":"additional","affiliation":[{"name":"Institute of Gastroenterology and Liver Diseases, Department of Medicine, Hadassah Hebrew University Hospital, Jerusalem, Israel."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaakov","family":"Maor","sequence":"additional","affiliation":[{"name":"Institute of Gastroenterology and Hepatology, Kaplan Medical Center, Rehovot, Israel."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Palak","family":"Trivedi","sequence":"additional","affiliation":[{"name":"National Institute for Health and Care Research Biomedical Research Unit and Centre for Liver Research, University of Birmingham, Birmingham, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Weston","sequence":"additional","affiliation":[{"name":"National Institute for Health and Care Research Biomedical Research Unit and Centre for Liver Research, University of Birmingham, Birmingham, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7635-9931","authenticated-orcid":true,"given":"Francesca","family":"Saffioti","sequence":"additional","affiliation":[{"name":"University College London Institute for Liver and Digestive Health, London, United Kingdom."},{"name":"Sheila Sherlock Liver Centre, Royal Free London NHS Foundation Trust, London, United Kingdom."},{"name":"Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Hall","sequence":"additional","affiliation":[{"name":"University College London Institute for Liver and Digestive Health, London, United Kingdom."},{"name":"Sheila Sherlock Liver Centre, Royal Free London NHS Foundation Trust, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1398-1541","authenticated-orcid":true,"given":"Massimo","family":"Pinzani","sequence":"additional","affiliation":[{"name":"University College London Institute for Liver and Digestive Health, London, United Kingdom."},{"name":"Sheila Sherlock Liver Centre, Royal Free London NHS Foundation Trust, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5610-5448","authenticated-orcid":true,"given":"Douglas","family":"Thorburn","sequence":"additional","affiliation":[{"name":"University College London Institute for Liver and Digestive Health, London, United Kingdom."},{"name":"Sheila Sherlock Liver Centre, Royal Free London NHS Foundation Trust, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amnon","family":"Peled","sequence":"additional","affiliation":[{"name":"Gene Therapy Institute, Hadassah Hebrew University Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adi","family":"Mor","sequence":"additional","affiliation":[{"name":"Chemomab Therapeutics Ltd., Tel Aviv, Israel."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"232","published-online":{"date-parts":[[2023,6,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2008.03.003"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI24282"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2015.03.017"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23294"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1007\/s11894-006-0067-8"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(00)80165-X"},{"issue":"1","key":"B7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1615\/CritRevImmunol.v19.i1.10","article-title":"Recent advances in chemokines and chemokine receptors","volume":"19","author":"Zlotnik","year":"1999","journal-title":"Crit Rev Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra052723"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1089\/107999002760624305"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-032713-120145"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2014.06.043"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.2174\/187152811798104890"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2012.11.004"},{"issue":"3","key":"B14","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.jhep.2020.09.033","article-title":"Role of CC chemokine receptor 9 in the progression of murine and human non-alcoholic steatohepatitis","volume":"74","author":"Morikawa","year":"2020","journal-title":"J Hepatol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2010.168"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1084\/jem.185.12.2171"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/mi.2015.94"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1172\/JCI0214097"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.169.5.2712"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.2001.01299.x"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2009.11.003"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1021\/pr501149m"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-215119"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1007\/s12031-019-01361-5"},{"key":"B25","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2015.00602","article-title":"Macrophages during the fibrotic process: m2 as friend and foe","volume":"6","author":"Braga","year":"2015","journal-title":"Front Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxu090"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/S1471-4906(02)02302-5"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1089\/jir.2005.25.82"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.175.8.5341"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2019.100064"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.14095"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2018.05.018"},{"key":"B33","article-title":"The emerging role of macrophages in chronic cholangiopathies featuring biliary fibrosis: an attractive therapeutic target for orphan diseases","volume":"7","author":"Cadamuro","year":"2020","journal-title":"Front Med (lausanne)"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2019.10.003"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06318-7"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1631-3"},{"key":"B37","doi-asserted-by":"crossref","DOI":"10.1038\/s41421-020-0157-z","article-title":"Single-cell RNA sequencing reveals the heterogeneity of liver-resident immune cells in human","volume":"6","author":"Zhao","year":"2020","journal-title":"Cell Discov"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1080\/14728222.2019.1608950"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26403"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2016.09.008"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1111\/liv.14498"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-014-0439-3"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1089\/jir.2013.0075"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1159\/000282062"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1097\/01.MIB.0000209790.21737.28"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2021.12.018"},{"issue":"suppl 1","key":"B47","article-title":"Functional role of intrahepatic monocyte subsets for the progression of liver inflammation and liver fibrosis in vivo","volume":"5","author":"Tacke","year":"2012","journal-title":"Fibrogenesis Tissue Repair"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00792"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-018-0300-8"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2013.01.055"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M406037200"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aaz4415"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-020-00558-8"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3390\/cells11030411"}],"container-title":["JCI Insight"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/insight.jci.org\/articles\/view\/162270\/files\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T21:52:32Z","timestamp":1779141152000},"score":1,"resource":{"primary":{"URL":"https:\/\/insight.jci.org\/articles\/view\/162270"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,22]]},"references-count":54,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2023,6,22]]},"published-print":{"date-parts":[[2023,6,22]]}},"alternative-id":["10.1172\/jci.insight.162270"],"URL":"https:\/\/doi.org\/10.1172\/jci.insight.162270","relation":{},"ISSN":["2379-3708"],"issn-type":[{"value":"2379-3708","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,22]]},"article-number":"e162270"}}